HIGHLIGHTS
- who: Godoy-Matos Diabetology Metabolic Syndrome and collaborators from the (UNIVERSITY) have published the research work: The role of glucagon on type 2 diabetes at a glance, in the Journal: (JOURNAL)
- what: The relevance of dysfunctional glucagon secretion to the pathogenesis of diabetes has been widely recognized and, for that reason, targeting glucagon and not only insulin secretion abnormalities in the treatment of T2D has gained increased interest.
SUMMARY
The protective mechanisms against hypoglycemia include suppression of insulin secretion and rise of counterregulatory hormones, especially glucagon and epinephrine. Somatostatin released by . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.